Reminder—Respond to Key Immunologic Events RFI by March 15

Funding News Edition: March 03, 2021
See more articles in this edition

As we described last month, NIAID is seeking community feedback on two broad topics:

  1. The utility, feasibility, and potential approaches to establishing a cohort of subjects at risk of developing autoimmune diseases and obtaining longitudinal samples from this cohort to identify immunologic events that drive disease onset in a productive, cost-effective, and minimally invasive manner.
  2. The feasibility of, potential approaches to, and impact of studies of autoimmune disease patient cohorts to define immunologic events that drive flares and remissions.

Email your comments to by March 15, 2021. Take care not to include any proprietary, classified, confidential, or sensitive information.

Contact Us

Email us at for help navigating NIAID’s grant and contract policies and procedures.

Content last reviewed on